Report Scope & Overview:
The Urinary Incontinence Treatment Devices Market Size was valued at USD 2.44 billion in 2022 and is expected to reach USD 4.46 million by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.
Urinary Incontinence (UI) is an illness that causes involuntary urination. When the person is unaware of it, it is also known as urine leaking. The various types of UI are Stress incontinence (leakage of urine due to pressure on the bladder caused by sneezing, coughing, etc. ), Uncontrollable compulsion incontinence (strong urge to urinate that results in unconscious loss of urine), Overflow incontinence (constant dripping of urine due to bladder that does not completely empty or bladder incontinence), and Mixed incontinence (constant dripping of urine due to bladder that does not completely empty or bladder (patient suffering from more than one type of urinary incontinence). Depending on the type of incontinence, doctors may offer different treatments.
To get more information on Urinary Incontinence Treatment Devices Market - Request Sample Report
Urinary incontinence is described as an uncontrollable, involuntary flow of pee caused mostly by a loss of bladder control. Pregnancy, diabetes, delivery, menopause, and spinal or pelvic surgery are all examples of conditions that can induce urinary incontinence. Urinary incontinence market growth is being driven by a rise in the frequency of medical conditions related to incontinence, as well as a growing older population. The market for urine incontinence treatment devices is predicted to grow as the number of diabetics having urinary difficulties rises. Furthermore, the rising prevalence of Parkinson's disease, new technologies in urinary incontinence, and the government's aggressive efforts to raise urine incontinence awareness are all driving the market two obstacles that may hamper market expansion is a lack of awareness of urinary urgency symptoms and post-surgery infections.
Introduction to new urinary catheters
Surgical treatment of Urinary incontinence
Increase in treatment rate
Shifting to other therapy
Low penetration of (UI)
Lack of knowledge
IMPACT OF COVID-19
The actual effect of the COVID-19 pandemic on key participants in the urinary incontinence business remained unfavorable. COVID-19 has caused widespread disruption in healthcare processes around the world. Numerous sectors, including several sub-domains of healthcare, have been forced to close their offices temporarily due to the disease. Several types of outpatient testing and treatments will be significantly reduced by 2020, with surgical treatments for female urine incontinence, infertility, kidney stones, and bladder stones seeing the most reductions.
By Product: The global urinary incontinence device market is currently dominated by vaginal slings, and this trend is projected to continue during the forecast period. Because of the significant priority for the use of biomaterials in the surgical treatment of incontinence, traditional vaginal slings account for a large portion of the vaginal slings market. Traditional vaginal sling advancements help to eliminate the post-operative difficulties connected with vaginal sling operations, and numerous prominent players are producing traditional vaginal slings employing sophisticated synthetic fabrics to satisfy the needs of patients.
By Category: The largest revenue was generated by the internal urinary incontinence device sector, and this trend is expected to continue throughout the projected period. This is due to a greater focus on the development of vaginal slings, as well as a rising demand for internal urethral devices.
By Incontinence: The global urinary incontinence devices market is dominated by the stress urinary incontinence (SUI) segment. This is due to the significant prevalence of stress urinary incontinence among women around the world. According to epidemiological studies on stress urinary incontinence in women, roughly 55% of women with urinary incontinence experience tension incontinence symptoms.
By End User: Urinary incontinence most typically affects women, and the frequency is high among hospitalized older individuals, therefore the hospital segment led the global market and is expected to continue this trend during the forecast period. As a result, the hospital market has seen the highest adoption of urinary incontinence equipment, owing to the vast patient pool suffering from chronic diseases or pregnancy.
KEY MARKET SEGMENTS:
Conventional Vaginal slings
Advanced Vaginal Slings
Electrical Stimulation Devices
Artificial Urinary Sphincters
By Incontinence Type
Stress urinary incontinence
Functional urinary incontinence
Urge urinary incontinence
Overflow urinary incontinence
Internal Urinary Incontinence Devices
External Urinary Incontinence Devices
By End User
Need any customization research on Urinary Incontinence Treatment Devices Market - Enquiry Now
North America, Europe, Asia-Pacific, Latin America, and the Caribbean are the regions involved. North America dominated the market, with the greatest share, and this dominance is predicted to continue during the forecast period. The Asia-Pacific region, on the other hand, showed the most growth. In the United States, Japan, and China, the urinary catheter market accounts for the majority of the overall market value. Urinary incontinence is more common as people get older in all places. In this regard, the aging population, together with longer life expectancies, will raise the market for urinary incontinence treatments in the future.
Concomitant illnesses, medicines, neuro-urine disorders, and other factors can all contribute to urinary incontinence in the elderly. The European market for urinary incontinence slings accounted for a significant bulk of the total market value. On the urinary incontinence sling market, both female and male urine incontinence slings are accessible. Slings for female urine incontinence are further divided into types. As individuals become more aware of the dangers of female urinary incontinence slings, this market is dwindling.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
The ajor Players are Boston Scientific Corporation, Promdon Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, and other players.
|Market Size in 2022||US$ 2.44 Billion|
|Market Size by 2030||US$ 4.46 Billion|
|CAGR||CAGR of 7.8% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product (Conventional Vaginal slings, Urinary Catheters, Advanced Vaginal Slings, Other Catheters, Vaginal Slings, Electrical Stimulation Devices, Foley Catheters, Artificial Urinary Sphincters, Other Devices)
• By Incontinence Type (Stress urinary incontinence, Functional urinary incontinence, Urge urinary incontinence, Overflow urinary incontinence)
• By Category (Internal Urinary Incontinence Devices, External Urinary Incontinence Devices)
• By End User (Clinics, Hospitals)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Boston Scientific Corporation, Promdon Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, and other players.|
|DRIVERS||• Introduction to new urinary catheters
• Surgical treatment of Urinary incontinencey
|RESTRAINTS||• Increase in treatment rate
• Limited factors
• Shifting to other therapy
Ans:- The Urinary Incontinence Treatment Devices Market Size was valued at USD 2.44 billion in 2022.
Ans: The Urinary Incontinence Treatment Devices Market is growing at a CAGR of 7.8% during the forecast period 2023-2030.
Key drivers of the Urinary Incontinence Treatment Devices Market are the Introduction of new urinary catheters and Surgical treatment of Urinary incontinence
Conventional Vaginal slings, Urinary Catheters, Advanced Vaginal Slings, Other Urinary Catheters, Vaginal Slings, Electrical Stimulation Devices, Foley Catheters, Artificial Urinary Sphincters, and Other Devices are the sub-segments by product type.
Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, and Fundamental Research.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
126.96.36.199 United Kingdom
188.8.131.52 South Korea
184.108.40.206 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Urinary Incontinence Treatment Devices Market Segmentation, by Product
8.1 Conventional Vaginal slings
8.2 Urinary Catheters
8.3 Advanced Vaginal Slings
8.4 Other Urinary Catheters
8.5 Vaginal Slings
8.6 Electrical Stimulation Devices
8.7 Foley Catheters
8.8 Artificial Urinary Sphincters
8.9 Other Devices
9. Urinary Incontinence Treatment Devices Market Segmentation, by Incontinence Type
9.1 Stress urinary incontinence
9.2 Functional urinary incontinence
9.3 Urge urinary incontinence
9.4 Overflow urinary incontinence
10. Urinary Incontinence Treatment Devices Market Segmentation, By CATEGORY
10.1 Internal Urinary Incontinence Devices
10.2 External Urinary Incontinence Devices
11. Urinary Incontinence Treatment Devices Market Segmentation, By End User
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Boston Scientific Corporation
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Promdon Group
13.3 Medtronic plc
13.4 Ethicon US
13.5 LLC. (Johnson & Johnson)
13.6 C. R. Bard, Inc. (Becton, Dickinson, and Company)
13.7 Coloplast Group
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare IT Consulting Market Size was valued at USD 46.35 billion in 2022 and is expected to reach USD 200.66 billion by 2030 and grow at a CAGR of 20.1% over the forecast period 2023-2030.
The Mammography Workstations Market Size was valued at USD 143.94 million in 2022, and is expected to reach USD 254.82 billion by 2030, and grow at a CAGR of 7.4% over the forecast period 2023-2030.
The Patient Access Solutions Market Size was valued at USD 1.84 billion in 2022, and is expected to reach USD 3.60 billion by 2030, and grow at a CAGR of 8.7% over the forecast period 2023-2030.
The Live Cell Encapsulation Market size was estimated USD 211.7 million in 2022 and is expected to reach USD 289.7 million by 2030 at a CAGR of 4.0% during the forecast period of 2023-2030.
The HIV Drugs Market size is expected to reach USD 47.80 Bn by 2030 and was valued at USD 31.70 Bn in 2022, the CAGR growth rate for HIV drug market is expected 5.6% over the forecast period of 2023-2030.
The Healthcare Technology Management Market size was estimated 6.92 USD billion in 2022 and is expected to reach USD 21.34 billion by 2030 at a CAGR of 15.12% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone